Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes.
paper
Cited
Public
Unavailable
- Authors
- Heinzen, Erin L; Radtke, Rodney A; Urban, Thomas J; Cavalleri, Gianpiero L; Depondt, Chantal; Need, Anna C; Walley, Nicole M; Nicoletti, Paola; Ge, Dongliang; Catarino, Claudia B; Duncan, John S; KasperaviciΕ«te, Dalia; Tate, Sarah K; Caboclo, Luis O; Sander, Josemir W; Clayton, Lisa; Linney, Kristen N; Shianna, Kevin V; Gumbs, Curtis E; Smith, Jason; Cronin, Kenneth D; Maia, Jessica M; Doherty, Colin P; Pandolfo, Massimo; Leppert, David; Middleton, Lefkos T; Gibson, Rachel A; Johnson, Michael R; Matthews, Paul M; Hosford, David; KΓ€lviΓ€inen, Reetta; Eriksson, Kai; Kantanen, Anne-Mari; Dorn, Thomas; Hansen, JΓΆrg; KrΓ€mer, GΓΌnter; Steinhoff, Bernhard J; Wieser, Heinz-Gregor; Zumsteg, Dominik; Ortega, Marcos; Wood, Nicholas W; Huxley-Jones, Julie; Mikati, Mohamad; Gallentine, William B; Husain, Aatif M; Buckley, Patrick G; Stallings, Ray L; Podgoreanu, Mihai V; Delanty, Norman; Sisodiya, Sanjay M; Goldstein, David B
- Year
- 2010
- Journal
- American journal of human genetics
- PMID
- 20398883
- DOI
- 10.1016/j.ajhg.2010.03.018
- PMCID
- PMC2869004
Deletions at 16p13.11 are associated with schizophrenia, mental retardation, and most recently idiopathic generalized epilepsy. To evaluate the role of 16p13.11 deletions, as well as other structural variation, in epilepsy disorders, we used genome-wide screens to identify copy number variation in 3812 patients with a diverse spectrum of epilepsy syndromes and in 1299 neurologically-normal controls. Large deletions (> 100 kb) at 16p13.11 were observed in 23 patients, whereas no control had a deletion greater than 16 kb. Patients, even those with identically sized 16p13.11 deletions, presented with highly variable epilepsy phenotypes. For a subset of patients with a 16p13.11 deletion, we show a consistent reduction of expression for included genes, suggesting that haploinsufficiency might contribute to pathogenicity. We also investigated another possible mechanism of pathogenicity by using hybridization-based capture and next-generation sequencing of the homologous chromosome for ten 16p13.11-deletion patients to look for unmasked recessive mutations. Follow-up genotyping of suggestive polymorphisms failed to identify any convincing recessive-acting mutations in the homologous interval corresponding to the deletion. The observation that two of the 16p13.11 deletions were larger than 2 Mb in size led us to screen for other large deletions. We found 12 additional genomic regions harboring deletions > 2 Mb in epilepsy patients, and none in controls. Additional evaluation is needed to characterize the role of these exceedingly large, non-locus-specific deletions in epilepsy. Collectively, these data implicate 16p13.11 and possibly other large deletions as risk factors for a wide range of epilepsy disorders, and they appear to point toward haploinsufficiency as a contributor to the pathogenicity of deletions.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Genome-wide rare copy number variations potentially associated with drug resistance in epilepsy. | Chakraborty A et al. | β | 2026 | β |
| Genotype-phenotype analysis of pathogenic copy number variations in pediatric epilepsy. | Zheng H et al. | β | 2026 | β |
| 16p13.11 deletion/duplication: a large cohort study on prenatal diagnosis, postnatal outcomes, and phenotypic manifestations. | Tang X et al. | β | 2025 | β |
| Cerebrotendinous Xanthomatosis: Novel EEG finding of Fixation-Off Sensitivity. | Mills Z et al. | β | 2025 | β |
| Classification of Brain Magnetic Resonance Imaging Abnormalities and Spectrum of Neurological Findings in a Cohort with Copy Number Variation-Related Disorders. | TΓΌrkyΔ±lmaz A et al. | β | 2025 | β |
| Structural variation, selection, and diversification of the NPIP gene family from the human pangenome. | Dishuck PC et al. | β | 2025 | β |
| Clinical and Genetic Characterization of Adolescent-Onset Epilepsy: A Single-Center Experience in Republic of Korea. | Han JY et al. | β | 2024 | β |
| Clinical phenotype of the 16p.13.11 microdeletion: a case report with a mini review of the literature. | Palumbi R et al. | β | 2024 | β |
| <i>De novo</i> and inherited micro-CNV at 16p13.11 in 21 Chinese patients with defective cardiac left-right patterning. | Yu K et al. | β | 2024 | β |
| Rare copy-number variants as modulators of common disease susceptibility. | Auwerx C et al. | β | 2024 | β |
| Copy-number variants as modulators of common disease susceptibility | Auwerx C et al. | β | 2023 | β |
| Generation and initial characterization of mice lacking full-length BAI3 (ADGRB3) expression. | Shiu FH et al. | β | 2023 | β |
| Genetic mechanisms in generalized epilepsies. | Wang X et al. | β | 2023 | β |
| Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals. | Montanucci L et al. | β | 2023 | β |
| 16p13.11 deletion variants associated with neuropsychiatric disorders cause morphological and synaptic changes in induced pluripotent stem cell-derived neurons. | Buttermore ED et al. | β | 2022 | β |
| 16p13.11 microdeletion/microduplication in fetuses: investigation of associated ultrasound phenotypes, genetic anomalies, and pregnancy outcome follow-up. | Cai M et al. | β | 2022 | β |
| Assessment of burden and segregation profiles of CNVs in patients with epilepsy. | Moreau C et al. | β | 2022 | β |
| A Unique Case of Aggressive Central Giant Cell Granuloma in a 10-Year-Old Boy With 16p13.11 Microdeletion Syndrome. | Shum BJ et al. | β | 2022 | β |
| Genetic and molecular features of seizure-freedom following surgical resections for focal epilepsy: A pilot study. | Louis S et al. | β | 2022 | β |
| Nde1 and Ndel1: Outstanding Mysteries in Dynein-Mediated Transport. | Garrott SR et al. | β | 2022 | β |
| Rates of rare copy number variants in different circumstances among patients with genetic developmental and epileptic encephalopathy. | Lee S et al. | β | 2022 | β |
| Whole Exome Sequencing in 16p13.11 Microdeletion Patients Reveals New Variants Through Deductive and Systems Medicine Approaches. | Granata P et al. | β | 2022 | β |
| Genetic diagnoses in pediatric patients with epilepsy and comorbid intellectual disability. | Yang M et al. | β | 2021 | β |
| Genome-Wide Association Analysis of Neonatal White Matter Microstructure. | Zhang J et al. | β | 2021 | β |
| Haploinsufficiency, Dominant Negative, and Gain-of-Function Mechanisms in Epilepsy: Matching Therapeutic Approach to the Pathophysiology. | Carvill GL et al. | β | 2021 | β |
| Somatic Focal Copy Number Gains of Noncoding Regions of Receptor Tyrosine Kinase Genes in Treatment-Resistant Epilepsy. | Vasudevaraja V et al. | β | 2021 | β |
| Chromosomal microarray analysis for pregnancies with or without ultrasound abnormalities in women of advanced maternal age. | Wu X et al. | β | 2020 | β |
| Clinical correlates in children with autism spectrum disorder and CNVs: Systematic investigation in a clinical setting. | Barone R et al. | β | 2020 | β |
| CNVs cause autosomal recessive genetic diseases with or without involvement of SNV/indels. | Yuan B et al. | β | 2020 | β |
| Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17β458 subjects. | Niestroj LM et al. | β | 2020 | β |
| Genetic Association of Epilepsy and Anti-Epileptic Drugs Treatment in Jordanian Patients. | Al-Eitan LN et al. | β | 2020 | β |
| Olfactomedin-3 Enhances Seizure Activity by Interacting With AMPA Receptors in Epilepsy Models. | Tang S et al. | β | 2020 | β |
| The path from scientific discovery to cures for epilepsy. | Carvill GL et al. | β | 2020 | β |
| 16p13.11-p12.3 Microdeletion identified in a patient with sagittal craniosynostosis and developmental delay. | MaldΕΎienΔ Ε½ et al. | β | 2019 | β |
| Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype. | Su L et al. | β | 2019 | β |
| Epilepsy genetics: Current knowledge, applications, and future directions. | Myers KA et al. | β | 2019 | β |
| GGC Repeat Expansion and Exon 1 Methylation of XYLT1 Is a Common Pathogenic Variant in Baratela-Scott Syndrome. | LaCroix AJ et al. | β | 2019 | β |
| Rare Variants in 48 Genes Account for 42% of Cases of Epilepsy With or Without Neurodevelopmental Delay in 246 Pediatric Patients. | FernΓ‘ndez-Marmiesse A et al. | β | 2019 | β |
| Submicroscopic aberrations of chromosome 16 in prenatal diagnosis. | Wu X et al. | β | 2019 | β |
| Chromosome 16p13.11 Microdeletion Syndrome in a Newborn: A Case Study. | Smith AE et al. | β | 2018 | β |
| Global characterization of copy number variants in epilepsy patients from whole genome sequencing. | Monlong J et al. | β | 2018 | β |
| Impacts of variants of uncertain significance on parental perceptions of children after prenatal chromosome microarray testing. | Desai P et al. | β | 2018 | β |
| Genetic and epigenetic mechanisms of epilepsy: a review. | Chen T et al. | β | 2017 | β |
| Genetic Testing in Pediatric Epilepsy. | Sands TT et al. | β | 2017 | β |
| GPR37L1 modulates seizure susceptibility: Evidence from mouse studies and analyses of a human GPR37L1 variant. | Giddens MM et al. | β | 2017 | β |
| NDE1 and NDEL1 from genes to (mal)functions: parallel but distinct roles impacting on neurodevelopmental disorders and psychiatric illness. | Bradshaw NJ et al. | β | 2017 | β |
| Prevalence of Pathogenic Copy Number Variation in Adults With Pediatric-Onset Epilepsy and Intellectual Disability. | Borlot F et al. | β | 2017 | β |
| Severe congenital microcephaly with 16p13.11 microdeletion combined with NDE1 mutation, a case report and literature review. | Tan L et al. | β | 2017 | β |
| When Should Genetic Testing Be Performed in Epilepsy Patients? | Poduri A | β | 2017 | β |
| Analysis copy number variation of Chinese children in early-onset epileptic encephalopathies with unknown cause. | Ma Y et al. | β | 2016 | β |
| Co-occurrence of 16p13.11 microdeletion and ring chromosome 20 syndrome. | Rodan LH et al. | β | 2016 | β |
| Finding the Missing Pieces: The Microdeletion Burden in GGE. | Mefford HC | β | 2016 | β |
| Identifying CNVs in 15q11q13 and 16p11.2 of Patients with Seizures Increases the Rates of Detecting Pathogenic Changes. | Vianna GS et al. | β | 2016 | β |
| Overlapping 16p13.11 deletion and gain of copies variations associated with childhood onset psychosis include genes with mechanistic implications for autism associated pathways: Two case reports. | Brownstein CA et al. | β | 2016 | β |
| Pathogenic copy number variants and SCN1A mutations in patients with intellectual disability and childhood-onset epilepsy. | Fry AE et al. | β | 2016 | β |
| Patient preferences for prenatal testing of microdeletion and microduplication syndromes. | Calonico E et al. | β | 2016 | β |
| Quantitative magnetic resonance imaging traits as endophenotypes for genetic mapping in epilepsy. | Alhusaini S et al. | β | 2016 | β |
| Recurrent copy number variations as risk factors for neurodevelopmental disorders: critical overview and analysis of clinical implications. | Torres F et al. | β | 2016 | β |
| Regulation of neuronal migration, an emerging topic in autism spectrum disorders. | Reiner O et al. | β | 2016 | β |
| 16p13.11 microdeletion in a patient with hemiconvulsion-hemiplegia-epilepsy syndrome: a case report. | Miteff CI et al. | β | 2015 | β |
| 6q22.1 microdeletion and susceptibility to pediatric epilepsy. | Szafranski P et al. | β | 2015 | β |
| Advancing epilepsy genetics in the genomic era. | Myers CT et al. | β | 2015 | β |
| A roadmap for precision medicine in the epilepsies. | EpiPM Consortium | β | 2015 | β |
| Burden analysis of rare microdeletions suggests a strong impact of neurodevelopmental genes in genetic generalised epilepsies. | Lal D et al. | β | 2015 | β |
| Clinical Genetic Testing in Epilepsy. | Mefford HC | β | 2015 | β |
| Concomitant deletion of chromosome 16p13.11 and triplication of chromosome 19p13.3 in a child with developmental disorders, intellectual disability, and epilepsy. | Tassano E et al. | β | 2015 | β |
| Copy number variations in children with brain malformations and refractory epilepsy. | Wincent J et al. | β | 2015 | β |
| Deletion 18p11.32p11.31 in a Child with Global Developmental Delay and Atypical, Drug-Resistant Absence Seizures. | Verrotti A et al. | β | 2015 | β |
| Detecting copy-number variations in whole-exome sequencing data using the eXome Hidden Markov Model: an 'exome-first' approach. | Miyatake S et al. | β | 2015 | β |
| Epilepsy genetics: the ongoing revolution. | Lesca G et al. | β | 2015 | β |
| Familial epilepsy in Algeria: Clinical features and inheritance profiles. | Chentouf A et al. | β | 2015 | β |
| Genetic Discoveries Drive Molecular Analyses and Targeted Therapeutic Options in the Epilepsies. | Dhindsa RS et al. | β | 2015 | β |
| Genomic analysis identifies candidate pathogenic variants in 9 of 18 patients with unexplained West syndrome. | Hino-Fukuyo N et al. | β | 2015 | β |
| Identification of Rare, Single-Nucleotide Mutations in NDE1 and Their Contributions to Schizophrenia Susceptibility. | Kimura H et al. | β | 2015 | β |
| Microdeletions of ELP4 Are Associated with Language Impairment, Autism Spectrum Disorder, and Mental Retardation. | Addis L et al. | β | 2015 | β |
| Regulatory domain or CpG site variation in SLC12A5, encoding the chloride transporter KCC2, in human autism and schizophrenia. | Merner ND et al. | β | 2015 | β |
| The genetics of neuropsychiatric diseases: looking in and beyond the exome. | Heinzen EL et al. | β | 2015 | β |
| The genetics of the epilepsies. | El Achkar CM et al. | β | 2015 | β |
| 16p11.2 600 kb Duplications confer risk for typical and atypical Rolandic epilepsy. | Reinthaler EM et al. | β | 2014 | β |
| A channel for precision diagnosis and treatment in genetic epilepsy. | Poduri A | β | 2014 | β |
| A genomic copy number variant analysis implicates the MBD5 and HNRNPU genes in Chinese children with infantile spasms and expands the clinical spectrum of 2q23.1 deletion. | Du X et al. | β | 2014 | β |
| An evaluation of copy number variation detection tools from whole-exome sequencing data. | Tan R et al. | β | 2014 | β |
| Clinical utility gene card for: 16p13.11 microdeletion syndrome. | Tropeano M et al. | β | 2014 | β |
| CNVs in Epilepsy. | Mefford HC | β | 2014 | β |
| Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. | McGrath LM et al. | β | 2014 | β |
| Copy number variation plays an important role in clinical epilepsy. | Olson H et al. | β | 2014 | β |
| Describing the genetic architecture of epilepsy through heritability analysis. | Speed D et al. | β | 2014 | β |
| Epilepsy: Beyond the single nucleotide variant in epilepsy genetics. | Scheffer IE et al. | β | 2014 | β |
| Exonic microdeletions of the gephyrin gene impair GABAergic synaptic inhibition in patients with idiopathic generalized epilepsy. | Dejanovic B et al. | β | 2014 | β |
| Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies. | International League Against Epilepsy Consortium on Complex Epilepsies. Electronic address: epilepsy-austin@unimelb.edu.au | β | 2014 | β |
| Genetic forms of epilepsies and other paroxysmal disorders. | Olson HE et al. | β | 2014 | β |
| Iterative phenotyping of 15q11.2, 15q13.3 and 16p13.11 microdeletion carriers in pediatric epilepsies. | JΓ€hn JA et al. | β | 2014 | β |
| Next-generation sequencing applied to rare diseases genomics. | Danielsson K et al. | β | 2014 | β |
| One gene, many neuropsychiatric disorders: lessons from Mendelian diseases. | Zhu X et al. | β | 2014 | β |
| SHC2 gene copy number in multiple system atrophy (MSA). | Ferguson MC et al. | β | 2014 | β |
| SNP arrays: comparing diagnostic yields for four platforms in children with developmental delay. | D'Amours G et al. | β | 2014 | β |
| Structural genomic variation in childhood epilepsies with complex phenotypes. | Helbig I et al. | β | 2014 | β |
| The expression and roles of Nde1 and Ndel1 in the adult mammalian central nervous system. | Pei Z et al. | β | 2014 | β |
| The genetics of microdeletion and microduplication syndromes: an update. | Watson CT et al. | β | 2014 | β |
| The scaffold protein Nde1 safeguards the brain genome during S phase of early neural progenitor differentiation. | Houlihan SL et al. | β | 2014 | β |
| What epilepsy comorbidities are important to model in the laboratory? Clinical perspectives. | Shorvon S | β | 2014 | β |
| A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk. | Chapman J et al. | β | 2013 | β |
| Array CGH in patients with developmental delay or intellectual disability: are there phenotypic clues to pathogenic copy number variants? | Shoukier M et al. | β | 2013 | β |
| Deletion 16p13.11 uncovers NDE1 mutations on the non-deleted homolog and extends the spectrum of severe microcephaly to include fetal brain disruption. | Paciorkowski AR et al. | β | 2013 | β |
| Diagnostic exome sequencing: a new paradigm in neurology. | Delanty N et al. | β | 2013 | β |
| Differences between RNA and DNA due to RNA editing in temporal lobe epilepsy. | Krestel H et al. | β | 2013 | β |
| Different electroclinical picture of generalized epilepsy in two families with 15q13.3 microdeletion. | Coppola A et al. | β | 2013 | β |
| Distribution of disease-associated copy number variants across distinct disorders of cognitive development. | Pescosolido MF et al. | β | 2013 | β |
| Does epilepsy in multiplex autism pedigrees define a different subgroup in terms of clinical characteristics and genetic risk? | Amiet C et al. | β | 2013 | β |
| Epilepsy with cognitive deficit and autism spectrum disorders: prospective diagnosis by array CGH. | Nicholl J et al. | β | 2013 | β |
| Fusion of large-scale genomic knowledge and frequency data computationally prioritizes variants in epilepsy. | Campbell IM et al. | β | 2013 | β |
| Inherited epilepsy in dogs. | Ekenstedt KJ et al. | β | 2013 | β |
| Male-biased autosomal effect of 16p13.11 copy number variation in neurodevelopmental disorders. | Tropeano M et al. | β | 2013 | β |
| Microdeletion syndromes. | Carvill GL et al. | β | 2013 | β |
| Molecular biology of epilepsy genes. | Williams CA et al. | β | 2013 | β |
| NDE1 and NDEL1: twin neurodevelopmental proteins with similar 'nature' but different 'nurture'. | Bradshaw NJ et al. | β | 2013 | β |
| Pediatric epilepsy genetics. | Pandolfo M | β | 2013 | β |
| Pleiotropy in complex traits: challenges and strategies. | Solovieff N et al. | β | 2013 | β |
| Rare exonic deletions of the RBFOX1 gene increase risk of idiopathic generalized epilepsy. | Lal D et al. | β | 2013 | β |
| Recent advances in the molecular genetics of epilepsy. | Hildebrand MS et al. | β | 2013 | β |
| Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. | Carvill GL et al. | β | 2013 | β |
| The epilepsy phenome/genome project. | EPGP Collaborative et al. | β | 2013 | β |
| The unexpected role of copy number variations in juvenile myoclonic epilepsy. | Helbig I et al. | β | 2013 | β |
| Unraveling the genetics of common epilepsies: approaches, platforms, and caveats. | Petrovski S et al. | β | 2013 | β |
| Advances in epilepsy genetics and genomics. | Kearney JA | β | 2012 | β |
| Application of array comparative genomic hybridization in 102 patients with epilepsy and additional neurodevelopmental disorders. | Bartnik M et al. | β | 2012 | β |
| Array comparative genomic hybridization: results from an adult population with drug-resistant epilepsy and co-morbidities. | Galizia EC et al. | β | 2012 | β |
| Atypical face shape and genomic structural variants in epilepsy. | Chinthapalli K et al. | β | 2012 | β |
| Canine epilepsy genetics. | Ekenstedt KJ et al. | β | 2012 | β |
| Chromosomal loss of 3q26.3-3q26.32, involving a partial neuroligin 1 deletion, identified by genomic microarray in a child with microcephaly, seizure disorder, and severe intellectual disability. | Millson A et al. | β | 2012 | β |
| Clinical review: Genome-wide association studies of skeletal phenotypes: what we have learned and where we are headed. | Hsu YH et al. | β | 2012 | β |
| Clinical utility of chromosomal microarray analysis. | Ellison JW et al. | β | 2012 | β |
| Copy number variation in patients with cervical artery dissection. | Grond-Ginsbach C et al. | β | 2012 | β |
| Current understanding of human genetics and genetic analysis of psoriasis. | Oka A et al. | β | 2012 | β |
| Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe. | Rubio JP et al. | β | 2012 | β |
| Developmental psychopathology: the role of structural variation in the genome. | Gill M | β | 2012 | β |
| Dissecting the genetic basis of myoclonic-astatic epilepsy. | Tang S et al. | β | 2012 | β |
| Duplication 12p and Pallister-Killian syndrome: a case report and review of the literature toward defining a Pallister-Killian syndrome minimal critical region. | Izumi K et al. | β | 2012 | β |
| Epi4K: gene discovery in 4,000 genomes. | Epi4K Consortium | β | 2012 | β |
| Epilepsy due to 20q13.33 subtelomere deletion masquerading as pyridoxine-dependent epilepsy. | Mefford HC et al. | β | 2012 | β |
| Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. | Heinzen EL et al. | β | 2012 | β |
| Fetal and maternal candidate single nucleotide polymorphism associations with cerebral palsy: a case-control study. | O'Callaghan ME et al. | β | 2012 | β |
| Genetic investigation for adults with intellectual disability: opportunities and challenges. | Baker K et al. | β | 2012 | β |
| Genome-wide copy number analysis uncovers a new HSCR gene: NRG3. | Tang CS et al. | β | 2012 | β |
| Genomics, intellectual disability, and autism. | Mefford HC et al. | β | 2012 | β |
| Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy. | Poduri A et al. | β | 2012 | β |
| Modifier genetics in neuropsychiatric disease: challenges and opportunities. | Ruzzo EK et al. | β | 2012 | β |
| Neuropathology of 16p13.11 deletion in epilepsy. | Liu JY et al. | β | 2012 | β |
| Opportunities and challenges for genome sequencing in the clinic. | Cavalleri GL et al. | β | 2012 | β |
| The genetic variability and commonality of neurodevelopmental disease. | Coe BP et al. | β | 2012 | β |
| Using ERDS to infer copy-number variants in high-coverage genomes. | Zhu M et al. | β | 2012 | β |
| 16p13.11 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders. | Ramalingam A et al. | β | 2011 | β |
| Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample. | McQuillin A et al. | β | 2011 | β |
| Clinical report: AN INTERSTITIAL deletion of 16p13.11 detected by array CGH in a patient with infantile spasms. | Balasubramanian M et al. | β | 2011 | β |
| Copy number variants: a new molecular frontier in clinical psychiatry. | Moreno-De-Luca D et al. | β | 2011 | β |
| Developments in molecular genetic diagnostics: an update for the pediatric epilepsy specialist. | Pong AW et al. | β | 2011 | β |
| Epilepsy and autism: neurodevelopmental perspective. | Tuchman R et al. | β | 2011 | β |
| Epilepsy and the new cytogenetics. | Mulley JC et al. | β | 2011 | β |
| Epilepsy genetics--past, present, and future. | Poduri A et al. | β | 2011 | β |
| Genetic contribution to common epilepsies. | Sisodiya SM et al. | β | 2011 | β |
| Genetic variations and associated pathophysiology in the management of epilepsy. | Mulley JC et al. | β | 2011 | β |
| Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research. | Hochstenbach R et al. | β | 2011 | β |
| Genome structural variation discovery and genotyping. | Alkan C et al. | β | 2011 | β |
| Genome-wide signatures of 'rearrangement hotspots' within segmental duplications in humans. | Uddin M et al. | β | 2011 | β |
| Genomic microdeletions associated with epilepsy: not a contraindication to resective surgery. | Catarino CB et al. | β | 2011 | β |
| Growth of genome screening needs debate. | Goldstein DB | β | 2011 | β |
| Heredity in epilepsy: neurodevelopment, comorbidity, and the neurological trait. | Johnson MR et al. | β | 2011 | β |
| High frequency of rare copy number variants affecting functionally related genes in patients with structural brain malformations. | Kariminejad R et al. | β | 2011 | β |
| Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. | Burnside RD et al. | β | 2011 | β |
| Neurobiology of attention deficit/hyperactivity disorder. | Purper-Ouakil D et al. | β | 2011 | β |
| Performance of genotype imputation for rare variants identified in exons and flanking regions of genes. | Li L et al. | β | 2011 | β |
| Pharmacogenomics and epilepsy: the road ahead. | Cavalleri GL et al. | β | 2011 | β |
| Phenotypic manifestations of copy number variation in chromosome 16p13.11. | Nagamani SC et al. | β | 2011 | β |
| Prioritization of epilepsy associated candidate genes by convergent analysis. | Jia P et al. | β | 2011 | β |
| Rare copy number variants are an important cause of epileptic encephalopathies. | Mefford HC et al. | β | 2011 | β |
| Uncovering genomic causes of co-morbidity in epilepsy: gene-driven phenotypic characterization of rare microdeletions. | KasperaviΔiΕ«tΔ D et al. | β | 2011 | β |
| Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. | KasperaviciΕ«te D et al. | β | 2010 | β |
| Ethical challenges in genotype-driven research recruitment. | Beskow LM et al. | β | 2010 | β |
| Genetically complex epilepsies, copy number variants and syndrome constellations. | Mefford HC et al. | β | 2010 | β |
| Great expectations: using massively parallel sequencing to solve inherited disorders. | Corbett M et al. | β | 2010 | β |
| Neurogenetics: advancing the "next-generation" of brain research. | Zoghbi HY et al. | β | 2010 | β |
| Neuropsychiatric connections of ADHD genes. | Burbach JP | β | 2010 | β |
| Phenotypic variability and genetic susceptibility to genomic disorders. | Girirajan S et al. | β | 2010 | β |